Evolving and Emerging Challenges in Biopreparedness
The complexity of dealing with emerging infectious diseases makes preparedness difficult.
Resolution of Scurvy in a Patient With a Spinal Cord Injury
At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.
Bivalent COVID-19 Boosters: Optimizing Vaccine Development and Infection Protection
Panel moderator Rodney Rohde, PhD, notes that word choice is important and clinicians should emphasize the COVID-19 vaccine is not a live virus but is instead designed to challenge the immune system to protect against the virus.
The ART of Implementing an Antiretroviral Stewardship Program
By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.
Sorry Ganciclovir, You’re Just Not the One for Me
Important clinical considerations to know about resistant CMV infections.
COVID-19 Convalescent Plasma: What Is Its Role in Therapy?
The key is using the right dose on the right patient at the right time.
CREating New Strategies for the Treatment of Resistant Gram-Negative Infections
This was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.
Back Again: Vaccines for RSV Near Approval
Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. FDA decisions on potential approvals for both could be forthcoming in the next few weeks.
A Candid Look Into Uncomplicated Candida Bloodstream Infection Treatment Durations
340B Drug Pricing Program: What Is It and Why Is It Important?
The 340B program has had a great impact on access to HIV treatment and prevention services in the US.
2 Commerce Drive Cranbury, NJ 08512